Monogalactosyldiacylglycerol Confers Fusogenicity to Liposomal Delivery Systems and Facilitates Targeting to Hepatocytes

References

• Chonn A., Cullis P. R. Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol 1995; 6: 698–708
   PubMed Web of Science ®Google Scholar
• Chonn A., Cullis P. R. Recent advances in liposome technologies and their applications for systemic gene delivery. Ad Drug Del Rev 1998; 30: 73–83
   PubMed Web of Science ®Google Scholar
• Webb M. S., Green B. R. Effects of neutral and anionic lipids on igalacto-syldiacylglycerol vesicle aggregation. Biochim Biophys Acta 1990; 1030: 231–237
   PubMed Web of Science ®Google Scholar
• Webb M. S., Green B. R. Biochemical and biophysical properties of thylakoid acyl lipids. Biochim Biophys Acta 1991; 1060: 133–158
   Google Scholar
• Lukacs G. L., Rotstein O. D., Grinstein S. Phagosomal acidification is mediated by a vacuolar-type H(+)-ATPase in murine macrophages. J Biol Chem 1990; 265: 21099–21107
   PubMed Web of Science ®Google Scholar
• Remy J. S., Kichler A., Mordvinov V., Schuber F., Behr J. P. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci U S A 1995; 92: 1744–1748
   PubMed Web of Science ®Google Scholar
• Dragsten P. R., Mitchell D. B., Covert G., Baker T. Drug delivery using vehicles targeted to the hepatic asialoglycoprotein receptor. Biochim Biophys Acta 1987; 926: 270–279
   PubMed Web of Science ®Google Scholar
• Shimada K., Kamps J. A. A. M., Regts J., Ikeda K., Shiozawa T., Hirota S., Scherphof G. L. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s. Biochim Biophys Acta 1997; 1326: 329–341
   PubMed Web of Science ®Google Scholar
• Spanjer H. H., van Berkel T. J., Scherphof G. L., Kempen H. J. The effect of a water-soluble tris-galactoside terminated cholesterol derivative on the in vivo fate of small unilamellar vesicles in rats. Biochim Biophys Acta 1985; 816: 396–402
   PubMed Web of Science ®Google Scholar
• van Berkel T. J., Kruijt J. K., Spanjer H. H., Nagelkerke J. F., Harkes L., Kempen H. J. The effect of a water-soluble tris-galactoside-terminated cholesterol derivative on the fate of low density lipoproteins and liposomes. J Biol Chem 1985; 260: 2694–2699
   PubMed Web of Science ®Google Scholar
• Spanjer H. H., Morselt H., Sherphof G. L. Lactosylceramide-induced stimulation of liposome uptake by Kupffer cells in vivo. Biochim Biophys Acta 1984; 774: 49–55
   PubMed Web of Science ®Google Scholar
• Spanjer H. H., Scherphof G. L. Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo. Biochim Biophys Acta 1983; 734: 40–47
   PubMed Web of Science ®Google Scholar
• Hara T., Kuwasawa H., Aramaki Y., Takada S., Koike K., Ishidate K., Tsuchiya S. Effect of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. Biochim Biophys Acta 1996; 1287: 51–58
   Google Scholar
• Murahashi N., Ishihara H., Sakagami M., Sasaki A. Synthesis and application of neoglycolipids for liposome modification. Biol Pharm Bull 1997; 20: 704–707
   PubMedGoogle Scholar
• Murahashi N., Ishihara H., Sasaki A., Sakagami M., Hamana H. Hepatic accumulation of glutamic acid branched neogalactosyllipid modified liposomes. Biol Pharm Bull 1997; 20: 259–266
   PubMed Web of Science ®Google Scholar
• Murahashi N., Sasaki A. In vivo behavior of liposomes modified with novel galactosyllipid derivative. Biol Pharm Bull 1996; 19: 418–423
   PubMed Web of Science ®Google Scholar
• Murahashi N., Sasaki A., Higashi K., Morikawa A., Yamada H. Relationship between the anchor structure of the galactosyl ligand for liposome modification and accumulation in the liver. Biol Pharm Bull 1995; 18: 82–88
   PubMedGoogle Scholar
• Lutwyche P., Cordeiro C., Wiseman D. J., St-Louis M., Uh M., Hope M. J., Webb M. S., Finlay B. B. Intracellular delivery and antibacterial activity of gentamicin encapsulated in pH-sensitive liposomes. Antimicrob Agents Chemother 1998; 42: 2511–2520
   PubMed Web of Science ®Google Scholar
• Webb M. S., Saxon D., Wong F. M. P., Lim H. J., Wang Z., Bally M. B., Choi L. S. L., Cullis P. R., Mayer L. D. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine. Biochim Biophys Acta 1998; 1372: 272–282
   PubMed Web of Science ®Google Scholar
• Fiske C. H., Subbarow Y. The colorimetric determination of phosphorous. J Biol Chem 1925; 66: 375–400
   Google Scholar
• Hope M. J., Walker D. C., Cullis P. R. Ca2+ and pH induced fusion of small unilamellar vesicles consisting of phosphatidylethanolamine and negatively charged phospholipids: a freeze fracture study. Biochem Biophys Res Commun 1983; 110: 15–22
   PubMed Web of Science ®Google Scholar
• Kumana C. R., Yuen K. Y. Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs 1994; 47: 902–913
   Google Scholar
• Tilcock C. P. S., Cullis P. R. The polymorphic phase behaviour of mixed phosphatidylserine-phosphatidylethanolamine model systems as detected by 31NMR. Effects of divalent cations and pH. Biochim Biophys Acta 1981; 641: 189–201
   PubMed Web of Science ®Google Scholar
• Düzgünes N., Straubinger R. M., Baldwin P. A., Friend D. S., Papahadjo-Poulos D. Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry 1985; 24: 3091–3098
   PubMed Web of Science ®Google Scholar
• Ellens H., Bentz J., Szoka F. C. H+- and Ca2+-induced fusion and desta-bilization of liposomes. Biochemistry 1985; 24: 3099–3106
   PubMed Web of Science ®Google Scholar
• Blom M., Andersson L., Carlsson A., Herslof B., Zhou L., Nilsson A. Pharmacokinetics, tissue distribution and metabolism of intravenously administered digalactosyldiacylglycerol and monogalactosyldiacylglycerol in the rat. J Liposome Res 1996; 6: 737–753
   Google Scholar